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Hodgkin's disease is a disease of unproven aetiology, varied histological
appearances and protean clinical manifestations. Exacerbations and remissions
make the immediate outlook at first unpredictable, although there is rarely any
doubt as to the ultimate outcome. These natural fluctuations make it difficult
to estimate the value ofany form oftherapy, so much so that it has been suggested
in the past that treatment has little real effect on the course of the disease. The
main method of treatment at the moment is still X-ray therapy, but recent
advances in the chemotherapeutic and hormonal control of cancer offer new
lines of attack that may prove fruitful in the future. To judge the true value of
any new agent of this type, a clear appreciation of the many factors influencing
the natural history of the disease is ofparamount importance. An agent offering
some hope of absolute cure would largely remove this need, but unfortunately
there is no sign that this will be available in the near future. We have therefore
attempted to assess those factors which appear to affect the natural evolution of
the process, and for this purpose have analysed all cases ofHodgkin's disease seen
at the Middlesex Hospital in recent years.
MATERIAL.
We have included in this series all cases ofHodgkin'sdiseaseseenat theMiddle-
sex Hospital between the years 1930 and 1952, provided that adequate histological
material was available for examination. Biopsy specimens from many patients,
particularly of those referred to the hospital during the war years, were no longer
available. Over 100 cases have been excluded for this reason. The final series
consisted of 227.
No selection of cases was made on their suitability for treatment. This would
have affected our conclusions as to the outlook in this disease, and vitiated the
object of the investigation. This series is not, therefore, strictly comparable
with many previously published, where the mode of treatment is often one of the
selection criteria. Many of our cases were far advanced when first seen, making
any form oftreatment ineffectual or impossible.
Although some of the patients were admitted and investigated in the general
wards of the hospital, the majority were referred directly to the radiotherapy
department, the diagnosis having been established elsewhere. The incidence
of the disease as seen at this hospital is therefore completely unrelated to its true
incidence amongst the populace at large.A. M. JELLIFFE AND A. D. THOMSON
CLINICAL FEATURES.
Extent of disease when first seen.
Hodgkin's disease presents with extremely varied clinical findings. The usual
course of the disease is one of a gradual, progressive enlargement of the lymph
nodes, at first limited in extent, later generalising and often finally invading struc-
tures otherthan lymphatic. In some cases there iswidespread involvement almost
from the onset, so much so, that the disease appears to be multifocal in origin.
At this stage, constitutional symptoms are usual, and changes in the blood picture
common.
The clinical staging of many tumours has sometimes been of great value, not
only in the assessment of prognosis, but also often allowing a more rational
approach to the treatment ofthe disease. The difficulties of clinical staging have
been discussed recently (Smithers et al., 1952) and with Hodgkin's disease the
problem is particularly complicated. Clinical examination may suggest that the
disease is limited to one area, whereas in actual fact there may already be wide-
spread involvement of the whole body. Before deciding that the disease is prob-
ably limited in extent, we would prefer to know that X-ray examination of the
chest is normal, that the patient is apyrexial and has no other constitutional
symptoms, and that the blood count is within normal limits.
All cases in this series have been staged according to the extent of the disease
when the diagnosis was first established. The system used resembles that of
Peters (1950), differing mainly in our definition of the third stage of widespread
disease (Table I). We consider that the presence of constitutional symptoms, in
TABLE I.-Staging of Hodgkin's Disease.
Stage I Lymph node involvement in only one main group.
Stage II . Lymph node involvement in 2 or more adjacent groups in either
upper or lower half of body.
Stage III . (a) Generalised lymph node involvement.
(b) Constitutional manifestations for which no other reasonable
cause can be found.
(c) Disease apparently limited to retroperitoneal lymph nodes.
(d) Involvement of structures other than lymphatic.
the absence of any other reasonable explanation, is certain evidence that the
disease has generalised. Unexplained pyrexia, pruritus, night sweats, and a blood
count showing a low haemoglobin, and a high polymorphonuclear count all suggest
advanced disease. A leucopenia, often with depression of red cell and platelet
elements is not infrequently found in the more fulminating cases.
All cases presenting with disease apparently limited to the retroperitoneal
lymph nodes, have also been included in the third stage, even in the absence of
constitutional symptoms, although at first sight, it would appear justifiable to
include them in Stage I. Not only was the tempo of these cases rapid, but also
the site made adequate irradiation difficult. Only three of our cases fall into this
group. In each, the presenting symptom was abdominal pain for which laparo-
tomy was performed. Survival after the diagnosis had been established were
12, 22, and 26 months. The outlook in this type of case therefore fully justifies
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its inclusion in the third stage. Most patients with retroperitoneal lymph glands
have severe constitutional symptoms or generalised disease and therefore fall
automatically into the advanced stage.
Invasion of extra-lymphatic structures may either occur late, in longstanding,
relatively benign cases, or occasionally as an early complication in the more
acute type of case. In either case the ultimate outlook is poor. Very rarely
the disease process apparently arises in, and is limited to, some unusual site.
For example, Hodgkin's disease macroscopically localised to the stomach has been
found at laparotomy, with no obvious evidence of spread elsewhere. This type
of case could be classed as early, and five-year survivals are obtainable ifadequate
resection or irradiation is possible (Slaughter and Craver, 1942).
Cases ofHodgkins' disease apparentlyarisinginthe skinhave not beenincluded
in our staging. Although only one organ is involved, the disease may cover
large areas of the body. In spite of this, the outlook may be very good, until
lymph node involvement finally develops. The disease then usually progresses
rapidly. Three of our cases presented originally in the skin, and these cases
have, therefore, been excluded from those tables including staged cases. Cases
developing skin invasion as the disease advances are, of course, included in the
third stage.
Examination of our results show that the outlook is very different in the three
stages (Table II). Fifty-nine per cent and 60 per cent respectively ofthe Stage I
TABLE II.-Hodgkin's Disease. Stage, Sex and Survival.
All cases All cases 5-year
1930-1952. 1930-1947. survivals.
Per- Per- Per- Per-
centage centage centage centage
of of of 5-year
Total. total. Total. total. Total. total. survival.
Male. . . 23 53 . 19 59 . 10 53 . 52
Stage I Female . 20 47 . 13 41 . 9 47 . 69
LBoth sexes . . 43 100 . 32 100 . 19 100 . 59
(Male. . 31 54 . 24 51 . 12 43 . 50
Stage II Female . 26 46 23 49 . 16 57 . 70
LBoth sexes . 57 100 . 47 100 . 28 100 . 60
(Male. . . 84 68 . 64 70 . 1 33 . 2
Stage III Female . 40 32 . 28 30 . 2 66 . 7
Both sexes . . 124 100 . 92 100 . 3 100 . 3
(Male. . . 138 62 . 107 63 . 23 46 . 21
All stages Female . . 86 38 . 64 37 27 54 . 42
Females 20-40 . - . 48 28
. 23 46
. 48
Both sexes . . 224 100 . 171 100 . 50 100 . 29
Three primary skin cases have been excluded. All percentages calculated to nearest whole
number.
and Stage II cases survive 5 years, compared with only 3 per cent ofthe Stage III
cases. Of the total of 124 Stage III cases, 8 died in under 4 weeks, 62, or 50 per
cent, died in under 1 year, and 107 or 86 per cent by the third year.
Fifteen cases ofthe entire series have survived for 10 years or longer. Ofthese,
6 were in Stage I, 9 were in Stage II and none in Stage III when first seen.
23A. M. JELLIFFE AND A. D. THOMSON
Duration of disease when first seen.
It is usually accepted that the outlook is better in malignant disease ifthe case
is not too advanced when the patient is first seen. But whatever the stage reached
by the disease, the time taken to reach that stage may be accepted as indicating
its general tempo, and the prognosis modified accordingly.
In our experience, Hodgkin's disease cannot be fitted into this general pattern.
It is often extremely difficult to assess the true duration of some cases, as consti-
tutional symptoms due to other diseases may have preceded its onset. Superficial
lymph nodes maybe unnoticed bythe patient forlongperiods, mediastinal involve-
ment may be detected only on X-ray examination of the chest, and involved
upper abdominal glands are notoriously difficult to detect at an early stage.
For the purpose of this analysis we have assumed that symptoms or signs fitting
into the diagnosis, and not satisfactorily explained by any other means, are due
to Hodgkin's disease, and have dated the onset accordingly.
In each stage, there are cases showing considerable variation in the duration
ofthe disease before the diagnosis was established. One Stage III patient noticed
a gradual enlargement of lymph glands for just under 9 years and died 2 months
after the diagnosis had been established. Another had a generalised enlargement
ofglands for only 1 month before a biopsy was taken, and yet he survived for 41
years. In 2 cases in Stage II the disease had been present for just under 2 years
before the diagnosis was established. The first case died 10 months later and the
second is still alive to-day, 19 years later, having had no further trouble. The
average duration before diagnosis of all cases in Stages I, II and III respectively,
was 11, 11 and 10 months. The total average duration before diagnosis of all
cases not surviving 5 years was 10 months, and of all cases surviving longer than
5 years, 14 months. This is not a very marked difference, and we do not consider
that the duration of the disease process before the diagnosis is established is of
any great value in assessing the prognosis. Offar greater importance is the stage
the disease has reached when the patient is first seen.
Age at the onset ofthe disease.
The age ofthe patients at the onset ofthe disease in this series varied between
2 and 78 years. The age distribution in the two sexes is shown on the accompany-
ing figure (Fig. 1). Jackson and Parker (1947) found that the prognosis in their
series was particularly poor in the very young and the very old and we agree with
their findings. Analysis of our series shows that the outlook is best in the third
and fourth decades, and this was particularly marked amongst the female cases.
Sex.
The total series of227 cases consisted of 139 males and 88 females, a proportion
similar to that usually reported by other authors.
Our results confirm the previously suggested view that the outlook is less
favourable in the male. Ofall cases seen before 1948, 50, or 29 per cent, survived
5 years. Of these 50, 54 per cent. were female and 46 per cent men, which is a
reversal of the initial sex incidence. Equally striking is the 48 per cent 5-year
survival rate amongst females in the third and fourth decades-a figure appreci-
ably greater than that of the general survival rate (Table II). It is true that 61
per cent ofthe males presented in Stage III, whereas only 46 per cent ofthe females
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were as far advanced when first seen. However, this cannot explain the difference
in survival rates, as in each individual stage, this sex difference was maintained.
PATHOLOGY.
The histological material ofthe patients forming this series has been examined
and classified into three sub-groups, as proposed by Jackson and Parker (1947).
These authors divide their cases of Hodgkin's disease into "paragranuloma ",
"granuloma" and "sarcoma ", according to the cellular characteristics displayed
in the lymph nodes.
In their series of cases there were 41 patients with paragranuloma. The prog-
nosis of this sub-group appears excellent, as 15 remain alive and well 5 years or
more after diagnosis, but 7 eventually progressed to the "granulomatous" form
ofthe disease.
There were 237 cases of "Hodgkin's granuloma" with an average prognosis
of 21 years, and 51 patients with "Hodgkin's sarcoma ", the majority of whom
were dead within a year of diagnosis.
According to these authors it would appear that each type ofHodgkin's disease
has a clearly distinguishable behaviour pattern and prognosis.
The prognosis of the sub-groups of the present series of Hodgkin's disease
does not entirely substantiate these findings, and, for reasons stated later, we
prefer to use the terms Hodgkin's disease Grade 1, 2 and 3 instead of the three
named sub-groups of Jackson and Parker.
Hodgkin's disease, Grade 1.
In this series of227 patients, the histology of 8 (4 per cent) showed the cellular
pattern corresponding to "paragranuloma ". The clinical features of this grade
are summarised in Table III. The average age at onset was 28 years. Six cases
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TABLE III.-Clinical Features. Hodgkin's Disease, Grade 1.
Case No. Age. Sex. Stage. Survival.
E72 . 12 . M II 19 years. Alive
M142 . . 32 . M . I 2 ,
B227 . . 28 . M . I 16 ,, Dead. Generalised
D62 . . 51 . F . I 4 ,, Alive. Recurred
D71 . . 51 . M . I .10 ,... ..
O'G159. . 13 . M . I . 5
M144 . . 26 . F . I . 11 ,, Dead. Generalised
M154 . . 24 . M . II . 2 ,, Alive
showed cervical node involvement only, 2 cases had both cervical and axillary
disease, and there were no examples ofgeneralised disease at the time ofpresenta-
tion.
All the patients were treated by irradiation and 6 remain alive and well from
2 to 19 years later. Two patients died in the 11th and 16th year with generalised
Hodgkin's disease. In one case autopsy showed that transformation had occurred
to the Grade 2 form. No autopsy was performed on the other fatal case.
Hodgkin's disease Grade 2.
Two hundred and two patients (88 per cent) showed the histological picture
corresponding to the Hodgkin's "granuloma" ofJackson and Parker (1947).
The average age at the time of onset of the disease varied from 2 to 78 years,
with an average of 35 years. There were 121 male and 81 female patients.
Table V summarises the prognosis of this grade of Hodgkin's disease. Of the
156 possible 5-year survivals, 111 were dead within 5 years of diagnosis. This
gives a survival figure of 29 per cent. Ifthis survival figure is assessed according
to the stage of the disease at the time of presentation it will be seen that of the
72 patients in Stages I and II, 42 remained alive at the end of 5 years, a survival
rate of58 per cent. Ofthe 84 cases in Stage III only 3 survived 5 years, a survival
rate of 4 per cent.
One patient survived 16 years, while 11 survived 10 years. A number of
cases have, however, succumbed to the disease within a few months of treatment
and the histological pictures in these cases differ in no recognisable way from the
more successfully treated patients ofthe same grade.
Hodgkin's disease, Grade 3.
There were 17 examples of the cellular type of disease (8 per cent) correspond-
ing to the Hodgkin's "sarcoma" ofJackson and Parker. The clinical features of
this group are summarised in Table IV.
The average age at onset was 44 years, and this grade appears to occur in an
older age group than Grades 1 and 2.
From Table IV it will be seen that 16 of the 17 cases are dead and survival
periods ranged from 1 month to 41 years. One death occurred 41 years after
diagnosis, 1 at 3 years and 2 at 2 years; thus the disease, although fatal, does not
necessarily kill rapidly.
Another feature of the Hodgkin's Grade 3 is the high percentage of Stage III
cases, so that the survival figures remain comparable to the other varieties of
Hodgkin's disease of a similar clinical staging. Nevertheless, as Table V shows,
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TABLE IV.-Clinical Features. Hodgkin's Disease, Grade 3.
Case No. Age.
C60 . . 78
B18 . . 63
B33 . . 61
H103 . . 26
L136 . . 30
M145. . 28
S185 . . 61
H115. . 49
C59 . . 19
W203. . 57
S180 . . 70
M138. . 42
E78 . . 38
T201 . . 59
S184 . . 44
B23 . . 9
H117 . . 14
Sex. Stage.
M . III
M . III
M . III
F . II
M . III
F . III
M . III
M . III
M . III
M . I
F . III
M . III
M . II
M . III
F . III
M . III
F . III
Survival.
5 months. Dead
2 years. ,,
1 month. ,,
1 years. ,,
1 year. ,,
7 months.
1 year. Alive
1 ,, Dead
6 months. ,,
4 ,. ..
13 . ..
4j years. ,,
4 months. ,,
3 years. ,,
2 , .
2 months. ,,
4 ,. ..
TABLE V.-Hodgkin's Disease. Grade, Stage and Survival.
Grade. Stage.
{ I
Grade 1 II
III
All stages
Possible
5-year
survivors.
4
1
0
5
I . 27
Grade 2 II . 45
III . 84
All stages . 156
I . 1
Grade 3 II . 1
III . 8
All stages . 10
I . 32
All J II . 47
grades III . 92
All stages . 171
5-year
survivors.
4
1
0
5
15
27
3
45
0
0
0
0
19
28
3
50
Percentage
5-year
survivals.
100
100
'0
100
55
60
4
29
0
0
0
0
59
60
3
29
ofthe 10 possible 5-year survivors not one patient in this small series attained that
figure.
DISCUSSION.
The purpose ofthe pathological section ofthis article is to assess the part that
histology can play in evaluating the prognosis ofa given case ofHodgkin's disease.
Jackson and Parker (1947) claimed a reasonably accurate assessment in their
series of cases, but we have been unable to substantiate the value of this work
in its entirety.
Hodgkin's disease, Grade 1.
This is clearly a histological entity which is diagnosable on lymph node biopsy
without knowledge of the clinical condition. Harrison (1952) gives an excellent
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description of the pathological features found in the lymph nodes in this disease
to which we have nothing to add (Fig. 2 and 3).
In view ofthe facts that local recurrence may follow treatment and the disease
may eventually change its characteristics, becoming generalised and fatal after a
period of years, it seems more realistic to regard this grade as a more slowly
progressive form of Hodgkin's disease without being a different disease entity.
The terms "paragranuloma ", "lympho-reticular medullary reticulosis" (Robb-
Smith, 1947) and "reticular lymphoma" (Lumb, 1954) suggest a different disease
process from the ordinarily accepted meaning of Hodgkin's disease, and were
presumably intended to do so. The title "Benign Hodgkin's Disease" conferred
upon it by Harrison (1952) appears particularly inappropriate for a condition that
may be fatal.
We prefer to denote this recognisable variety of Hodgkin's disease by the non-
committal term, Hodgkin's disease, Grade 1. This implies a lesion with the
clinical and histological characteristics of Hodgkin's disease, but of a lower grade
malignancy with potentialities for eventual generalisation in some cases.
Hodgkin's disease, Grade 2.
As in Jackson and Parker's series this forms the bulk of the cases.and histo-
logically the cellular appearances of the lymph nodes are those generally accepted
and described in every text-book of pathology (Fig. 4 and 5).
The prognosis in this type of disease is extremely variable and appears to be
modified by treatment (Gilbert, 1939). Cases with a virtually identical histo-
logical pattern may live for 15 years, or, conversely, die within a few months of
diagnosis. The prognosis appears more closely related to the clinical staging
and although an average prognosis of 29 per cent 5-year survival can be given
for the whole group the histological pattern has no part to play in the accurate
prognostic assessment ofthis grade of Hodgkin's disease.
The name, "Hodgkin's granuloma ", seems inappropriate as implying a non-
neoplastic, chronic inflammatory aetiology; an assumption which is not very
realistic for such a widely disseminated and invariably fatal disease.
A more logical approach to nomenclature is Hodgkin's disease, Grade 2. This
implies a disease process of unknown aetiology showing the microscopical appear-
ances ofaccepted Hodgkin's tissue and demarcating it from the Grade 1 and Grade
3 counterparts.
EXPLANATION OF PLATE.
FIG. 2.-Hodgkin's Disease, Grade 1. Showing loss ofthe normal architecture ofthe lymph node
due to lymphocytes and conspicuous giant cells. X 100.
FIa. 3.-Hodgkin's Disease, Grade 1. Showing the giant cells embedded in a predominantly
lymphocytic stroma. x 500.
FIG. 4.-Hodgkin's Disease, Grade 2. Showing loss of the normal architecture of the lymph
node with areas of fibrous tissue and cellular foci containing giant cells. x 100.
FIG. 5.-Hodgkin's Disease, Grade 2. Showing the cellular pleomorphism with giant cells,
reticulo-endothelial cells, polymorphonuclear leucocytes. x 500.
FIG. 6.-Hodgkin's Disease, Grade 3. Showing the loss of the normal architecture with a
marked cellularity and many giant cells. x 100.
FIG. 7.-Hodgkin's Disease, Grade 3. Showing the pleomorphism of the cells with giant cells,
conspicuous reticulo-endothelial overgrowth and mitotic activity. X 500.
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Hodgkin's disease, Grade 3.
This grade of Hodgkin's disease has ill-defined limits; at one end of the scale
it merges into the Grade 2 type and at the other end with reticulum cell sarcoma.
As Jackson and Parker (1947) state, the one diagnostic feature is the presence of a
variable number of Dorothy Reed giant cells in an actively growing reticulo-
endothelial cell proliferation. To add to the confusion, Jackson and Parker's
photomicrographs are not diagnostically informative and Custer and Bernhard
(1948) regard the Hodgkin's sarcoma as virtually synonymous with reticulum
cell sarcoma.
However, there does appear to be a smallnumber of cases in this series showing
the characteristic cellular pleomorphism of Hodgkin's disease containing the
diagnostic giant cells. In addition, there is an abnormally active reticulo-
endothelial cell overgrowth with frequent mitotic figures and local areas of
necrosis. The appearances resemble an actively growing tumour and the fibrous
tissue, so prominent in the Grade 2 counterpart, is scanty. This type is called
Hodgkin's disease, Grade 3, to denote a pathological process at the more cellular
and malignant end of the scale of Hodgkin's disease (Fig. 6 and 7). In this sub-
group the tempo ofthe disease is extremely rapid, and 12 ofthe 16 deaths occurred
within 18 months ofdiagnosis. No case survived for more than 41 years.
Other features are worthy of comment in this series as a whole. There is an
apparent therapeutic success in female patients with Hodgkin's disease restricted
to the mediastinum and cervical regions. This success may be due to confusion
of the histological appearances with the granulomatous form of malignant thy-
moma (Eisenberg and Sahyoun, 1950; Thomson, 1955).
In 29 cases, serial biopsies were available. In 11 cases an increased cellularity
of the Hodgkin's tissue was detectable in the subsequent pathological material
as the disease progressed. We found no examples of complete cellular alteration
necessitating a different diagnosis, as did Custer and Bernhard (1948).
TREATMENT.
Bearing in mind the many factors influencing the course of Hodgkin's disease,
it is difficult to assess the true value ofanyform oftreatment. Ofthe 227 patients
in this series, 14 were untreated; 5 presented in Stage I, and 9 in Stage III.
The average survival after diagnosis was under 4 months in the last group, and 41
months in the first. One Stage I case survived for just over 5 years. These
cases cannot be considered an adequate control series. Firstly, the number was
small and the overall figures must be unduly influenced by a few good or bad
results. Secondly, there was definite selection of the Stage III cases, 4 being
considered too advanced for any attempt at treatment. They do, however,
emphasize again the totally different outlook in these two stages.
Surgical resection of the diseased area has been recommended as the ideal
method oftreatment, when technically possible (Baker and Mann, 1940). Slaugh-
ter and Craver (1942) quote 5 patients alive and well, 5, 6, 8, 11 and 11 years
after removal of the affected lymph nodes by block dissection. Three of our
patients were treated in this manner, but in each case the operation was followed
by X-ray therapy. One patient had developed lymph glands in the adjacent
supra-clavicular triangle by the time X-ray therapy was commenced, a few weeks
after an apparently successful dissection. One case has survived for 5 years.
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There does not appear to be much place for this method of treatment. If the
disease is genuinely limited to one area, its extreme radio-sensitivity makes radical
X-ray therapy the ideal method for general purposes. In very exceptional cases
the disease may be so localised that complete resection is possible, and occasionally
it may arise at some unusual site, such as the stomach, where adequate irradiation
is difficult. Resection in this type of case would offer the only real hope of long
survival (Slaughter and Craver, 1942).
Irradiation has been the main method oftreatment in the majority ofour cases.
A few ofthe earlier patients were exposed to radium, either in the form of a surface
applicator, teleradium, or needle implant. Since the earlier years all irradiation
has been by means of 170-250 kv. X-rays, 1-3'8 mm. Cu h.v.l. Throughout
various centres, there is considerable difference ofopinion as to the most effective
methods of treatment (Medinger and Craver, 1942; Peters, 1950; Levitt, 1952;
Nice and Stenstrom, 1954). We have analysed all cases treated initially by
deep X-rays, in an attempt to assess the dose necessary to ensure local cure of
involved nodes. Excluding all Stage III cases, the remainder can be placed in
three main groups. The first includes those cases with complete disappearance
ofthe treated nodes, and no recurrence, locally or elsewhere, the patient known to
have had no further trouble, for a period of 5 years or longer (Table VI). The
TABLE VI.-Cases Without Recurrence after First Treatment.
X-ray
dosage Survival
Stage. (t.d.). (years).
I 2000 r . 64
I . 2100 r . 5
I . 3000 r 8
II . 3000 r 12
II . 3500 r . 19
II . 4000 r 14
II . 3730 r . 8
II . 6400 r . 11
t.d.: Tumour dose.
second includes all cases where disappearance ofthe nodes was followed by a first
recurrence at the previously treated site (Table VII). By doing so, those cases are
excluded where apparently local recurrence could have been caused by retrograde
spread from adjacent involved areas. All cases in the second group received a
dose ofat least 2000 r and 6 received at least 3000 r. Amongst those cases with the
first recurrence at the previously treated site, 13 were given 2200 r orless, and none
received more than 3000 r. The total number of cases is small, but this suggests
that complete local resolution is probable above a dose of 3000 r, while a local
recurrence is more likely if less than this amount of X-ray therapy is given.
From this it follows that reasonably localised disease should be treated to a level
of at least 3500 r over 34 to 4 weeks, provided that this is technically possible, if
an attempt is to be made at a radical cure.
Wide fieldirradiation maybenecessaryinthelaterstages of the disease. Large
volumes ofbody tissue cannot be raised to such dose levels with safety, and pallia-
tion of a more temporary nature is the most that can be expected.
The cytotoxic poisons have been used at the Middlesex Hospital withincreasing
frequency since their introduction by Wilkinson (Wilkinson and Fletcher, 1947).
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TABLE VII.-Cases with First Recurrence at Site of Previous Irradiation.
X-ray
dosage
Stage. (t.d.). Recurrence.
I . 400 r 3 years
I . 1000 r . 4
I . 2000 r . 1 year
I . 3000 r . 1 years
I . 3000 r . 1 year
II . 1000 r 2 years
II . 1000 r . 5
II . 1050 r . 6 months
II . 1150r . 4 ,,
II . 1500 r . 3 ,,
II . 1800 r . 6 ,,
II . 1800 r . 7 ,,
II . 2200 r . 6
II . 2200 r . 3 years
II . 2400 r . 10 months
II . 3000 r . 3 years
t.d.: Tumour dose.
The majority of cases have been given nitrogen mustard, often in repeated courses.
Their use has been well reviewed recently by Beatty and Howells (1954). There
does not appear to be any evidence available that these agents are preferable
to X-rays in the treatment of localised Hodgkin's disease. Almost all our cases
treated with these agents had widespread disease, and it is therefore hardly
surprising that responses have been short-lived. Nitrogen mustard was given as
the first method oftreatment in only 5 cases. Survivals after treatment were 34,
33, 23, 5 and 2 months. This is not a fair comparison with those cases treated by
X-rays, as 4 ofthe 5 were in Stage III. The one early case, agirl of23, withdisease
limited to the cervical glands on one side, had a remission of 9 months following
which the disease progressed rapidly. The danger of severe and possibly fatal
depression of all the bone marrow elements is common to both the cytotoxic
poisons and to wide field irradiation. There does not appear to be any logical
reason for their use in apparently localised disease, when local irradiation can be
given to a high dose level without any severe general body effects. Even when
indicated by widespread disease, care is needed in their administration, but
provided adequate control is maintained they have an important place in the
management of Hodgkin's disease.
COMPLICATIONS.
Hodgkin's disease is almost invariably fatal. The exact cause of death may
be difficult to ascertain; and was often so in this series. It was frequently
difficult to obtain precise clinical details or post-mortem findings, as many of the
patients died at home or in other institutions. In some cases the disease was so
widespread at autopsy that the exact cause of death could not be decided. In
spite ofthis, a review ofthe common complications occurringin this series revealed
some points of importance. It is probable that in some cases their earlier recog-
nition and more adequate treatment might have led to the prolongation ofuseful
life.
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Pregnancy.-As with tuberculosis, it has often been held that pregnancy
is contra-indicated in Hodgkin's disease, in that it is frequently followed by an
exacerbation ofthe disease process. Eight patients in this series became pregnant.
We found no evidence that this occurrence altered an any way the tempo of the
disease, but no reasonable conclusions can be drawn from such a small series.
Stewart and Munro (1952) have reviewed the subject. After analysing 134
reported cases, they conclude that pregnancy has no predictable effect on the
course ofthe disease.
Blood abnormalities occurred frequently as the disease progressed. An
anaemia was the rule in the more advanced cases. This was not usually of a
severe degree, and was correctable by transfusion and by treatment of the under-
lying disease. In some cases it became a major problem, and repeated trans-
fusions failed to raise the haemoglobin above dangerously low levels. None of
these cases had any obvious blood loss from any site. Two patients developed
a haemolytic anaemia; one as a terminal complication for which nothing could
be done, while the other responded well to cortisone, followed by splenectomy.
Leucopenia and thrombocytopenia, often associated with a low haemoglobin
level, were frequently found at a late stage in the disease. The majority of cases
appear to have followed either invasion of the bone marrow or prolonged treat-
ment with the cytotoxic poisons or X-rays. The leucopenia is often a deciding
factor, preventing further treatment and predisposing the victim to secondary
infections. It is therefore important to conserve the bone marrow for as long
as possible, and it is probably advisable to avoid the use ofcytotoxic poisons and
wide field irradiation, unless they are indicated by generalised disease.
An eosinophilia is found in under 10 per cent of all cases of Hodgkin's disease.
In our experience an increase of the eosinophil count above the normal range was
found only when widespread disease was present, when there was macroscopic
invasion of the skin, or when the patient complained of pruritus. We therefore
consider that an eosinophilia, if present, suggests that the disease is widespread.
The only exception to this was seen in those cases with skin invasion astheprimary
manifestation. As has been mentioned previously, the outlook in this type of
case appears to be extremely variable, and an eosinophilia cannot then be con-
sidered a sign ofpoor prognosis.
Intrathoracic spread is extremely common, occurring in the majority of cases.
Hilar gland enlargement is, ofcourse, the commonest form, occurring at some stage
in two-thirds of our cases. This finding does not appear to influence the prognosis
adversely. Twenty-nine of the cases in Stage II when first seen had hilar gland
enlargement on X-ray examination of the chest. Sixteen or 55 per cent, of these
cases survived for more than 5 years Only one of the 227 patients developed
clinical signs of superior vena caval obstruction.
The presence of parenchymal pulmonary involvement is, however, of more
serious import. Diffuse infiltration of the lung fields was found commonly in
the late stages of the disease, and 5 patients developed discrete rounded intra-
pulmonary opacities. No case with parenchymal infiltration responded satis-
factorily to treatment. One patient died of haemorrhage from a main branch
of the right pulmonary artery, which ruptured into the centre of a necrotic mass
of Hodgkin's tissue.
Intra-abdominal spread involving the retroperitoneal glands occurs at some
stage in the majority ofpatients with Hodgkin's disease.
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In the present series, retroperitoneal gland involvement was found, either
clinically, or at autopsy in over one half of all cases. Once this complication
occurred the outlook became gloomy, as involvement ofthe renal tract and hepatic
system were common sequelae. Probably a number of the cases of so-called
"Hodgkin's cachexia" were unrecognised cases of uraemia. In addition the
commonest site of extra-dural deposits of Hodgkin's tissue is in the lower dorsal
and upper lumbar spine, presumably from direct spread backward from the retro-
peritoneal tissues. Thirteen of the 16 cases of paraplegia in this series occurred
in this region.
The difficulties of treating a large mass of glands in the upper abdomen have
already been mentioned, and diagnosis at an earlier stage may be extremely
difficult. There may be nothing to feel on abdominal examination, but a history
of recurrent attacks of upper abdominal pain, often radiating through to the
middle of the back and waking the patient in the small hours of the morning is
very suggestive of retroperitoneal spread. Intravenous pyelography may be a
useful confirmatory investigation, demonstrating displacement of the kidneys or
ureters. If no other cause can be found, irradiation of the affected area usually
leads to a rapid improvement of symptoms, thus confirming the provisional diag-
nosis.
Nervous system involvement is a common complication ofHodgkin's disease.
In this series, 8 patients developed actual invasion ofperipheral nerves, includ-
ing the brachialplexus, cervical sympathetic chain, and oculomotor and recurrent
laryngeal nerves. Two patients developed a multiple peripheral neuritis. All
cases were advanced, and the ultimate prognosis was unaffected by these compli-
cations.
Coma was known to occur as a terminal event in at least 17 of the patients,
associated in some cases with convulsions and preceded by mental disturbances.
In some of these cases the clinical appearance of the patient suggested the possi-
bility of the development of intra-cerebral deposits. In fact no such invasion
was found in any case at post-mortem examination. Thisresultis not unexpected,
as there are only four acceptable examples ofbrain invasion in the world literature
reviewed recently by Fein and Newill (1954). One patient was found at post-
mortem examination to have an intra-cranial extradural deposit of the disease.
Extradural deposits with paraplegia developed in 16 cases, 9 without obvious
change in the vertebral column on X-ray examination. The importance of the
early recognition and treatment of this complication is well illustrated by one
patient who lived a normal life for 4 years following laminectomy and irradiation
of the affected cord segment, until further generalisation of the disease occurred.
Paraplegia may develop at any state ofthe disease, and in 2 ofthe 16 cases it was
the presenting symptom. This subject is well reviewed by Smith and Stenstrom
(1948).
Herpes zoster occurred in 27 patients. This is a significant complication, as it
was followed within 3 months by an exacerbation of the underlying Hodgkin's
disease in all except 2 cases.
Secondary infection.-This complication is probably ofless importance follow-
ing the introduction of the antibiotics, but it is always potentially dangerous in
the later stages of the disease, when the polymorphonuclear count is low.
Tuberculosis has long been associated with Hodgkin's disease, so much so that
a common cause has often been postulated. Seven patients in this series devel-
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oped tuberculous lesions. This does not appear to be excessively frequent in a
disease which may be both debilitating and long-standing. Part, at any rate, of
this traditional association may be due to misdiagnosis. Five case of Hodgkin's
disease were thought, on clinical examination, to have tuberculous glands of the
neck, and were treated as such for variable periods before the correct diagnosis
was finally made by biopsy. One of these patients was considered tuberculous
for over 4 years, one of which was spent in a sanatorium. In the late stages of
the disease, pulmonary infiltration with Hodgkin's tissue is very common, giving
X-ray appearances that may be indistinguishable from those seen in pulmonary
tuberculosis.
In all our tuberculous patients the underlying Hodgkin's disease was already
advanced and the outlook, therefore, extremely poor. Four deaths were un-
doubtedly directly due to tuberculosis. Presumably, with modern antibiotics,
the prognosis is now better in this type of case.
Complications unrelated to Hodgkin's disease.
It is very easy to miss the development of a new disease in the course of a
chronic illness. Additional complications may be attributed to the original
complaint with fatal results. Three of our patients developed a perforation of a
duodenal ulcer. Two were seen elsewhere, the pain was attributed to Hodgkin's
disease and the correct diagnosis only established at post-mortem examination.
One case was recognised and successfully dealt with. A proven peptic ulcer
occurred in 7 patients, and was a constant source ofdifficulty in diagnosis, the pain
being confused with that found with retro-peritoneal gland involvement. This
high incidence may be attributed to the constant nervous tension under which
the majority of these unfortunate patients must live.
CONCLUSIONS.
The relative merits of the different forms of treatment in Hodgkin's disease
cannot be evaluated successfully unless the cases under review are strictly com-
parable. An analysis of this series suggests that many factors affecting both the
natural history and prognosis of the disease can be clearly recognised.
The important features which determine the eventual prognosis include the
stage reached by the disease at the time of presentation, the histological appear-
ances, the age at onset and the sex ofthe patient. In our experience the duration
ofthe disease before treatment has proved of little prognostic value, as it is often
impossible to assess this factor accurately.
Staging ofthe disease at the time ofthe initial clinical examination has proved
of considerable value Ofthe patients placed in Stages I and II about 50 per cent
are alive at 5 years, while those inStage III at the time ofpresentation veryrarely
survive this period. During the earlier years covered by this series some of the
patients included in Stages I and II were insufficiently investigated to exclude
completely early generalisation of the disease. The ensuing short survival of
many ofthese patients suggests that, with more searching clinical, radiological and
haematological investigation, some of these cases would have been more accur-
ately placed in the Stage III category ofthe disease. Ifthis assumption is correct
the outlook in the Stages I and II would compare even more favourably with
Stage III.
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There does appear to be some difference in the prognosis of the various age-
groups and between the two sexes. An analysis of the results suggests that the
best survival rate is found in young women in the third and fourth decades.
Unfortunately, the number of patients in this series is small and further sub-
division ofthe cases into groups according to the age and sex renders more detailed
analysis of doubtful significance.
Histological examination of biopsy material is essential as the sole method of
establishing the specific diagnosis. In the absence of histological proof both the
diagnosis and, therefore, the prognosis remain entirely conjectural. It is possible
to recognise three histological grades in Hodgkin's disease, each with a signi-
ficantly differing averageprognosis. All the patients with a Grade 1 microscopical
appearance were alive 5 years after diagnosis, while no histologically Grade 3
patient survived this period. Taking each grade separately, it was not possible
to decide on histological grounds alone which individual case would fare better
or worse than the average within that grade.
Eighty-eight per cent of the cases ofthis series have a Grade 2 type of cellular
picture, and there is no recognisable histological distinction between those patients
who survive for 15 years and those who succumb to the disease in as many weeks.
This is the majorlimitation ofthe histological grading ofHodgkin's disease. How-
ever, it is extremely valuable in assessing the prognosis as a whole to recognise
both the Grade 1 and Grade 3 varieties of the disease, although these account for
only a small percentage ofthe series.
Although many ofthe complications ofHodgkin's disease, such as parenchymal
lung involvement and retroperitoneal spread, cannot be effectively treated, there
remain a few where early recognition and treatment are ofparamount importance.
These include the development of paraplegia associated with extradural deposits
of Hodgkin's tissue, acquired haemolytic anaemia, secondary infection including
tuberculosis and the occurrence of peptic ulceration.
No dogmatic statement can be made as to the precise value of the treatment
given to the patients in this series. The few untreated cases were largely selected
in that the disease was advanced; similarly, the cytotoxic poisons were rarely
used in either early cases or as the primary method of treatment. As regards
irradiation, it does appear possible to eradicate local disease for a variable and,
in some cases a considerable, length of time provided sufficient dosage is given.
Heavy irradiation, in excess of3000 r, is possible onlywhen the disease is limited in
extent, but it does appear a justifiable method oftreatment in this type of case.
SUMMARY.
Two hundred and twenty seven cases of Hodgkin's disease are reviewed.
The prognosis in an individual case appears to depend on many factors, including
the stage of the disease at the time of presentation, the age of onset, the sex of
the patient and the histological appearance. Progress of Hodgkin's disease is
modified bytreatment, butthetruevalueofanyformoftherapycannot be assessed
unless the other prognostic factors are considered.
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